European Cancer Diagnostics Market Set for Significant Growth to Reach USD 126 Billion by 2033 Amid Rising Incidence and Advancements in Technology

Posted on 2024-10-03 by Future Market Insights in Healthcare // 0 Comments

The European cancer diagnostics market is predicted to experience remarkable growth over the forecast period, with a compound annual growth rate (CAGR) of 5.2% from 2023 to 2033. This growth is fueled by increasing cancer incidence rates, technological advancements in diagnostics, and a growing emphasis on early detection strategies across the region.

At the global level, the cancer diagnostics market is projected to expand at a robust CAGR of 8.5%, surging from USD 55.71 billion in 2023 to an impressive USD 126 billion by 2033. This significant growth is indicative of a heightened global focus on improving diagnostic technologies and enhancing cancer care outcomes.

Key Market Drivers

Rising Cancer Incidence: With cancer remaining one of the leading causes of death globally, the demand for more effective and early-stage diagnostic tools is at an all-time high. Europe’s aging population and lifestyle changes have further contributed to a surge in cancer cases, driving the need for advanced diagnostics.
Technological Advancements: Innovations in molecular diagnostics, liquid biopsies, imaging technologies, and AI-driven diagnostic tools are revolutionizing cancer detection and treatment planning. These advancements are enabling more precise and non-invasive detection methods, which are being rapidly adopted across Europe.
Emphasis on Early Detection: Governments and healthcare organizations across Europe are increasingly prioritizing early detection and screening programs to improve cancer survival rates. This is creating a demand for advanced diagnostic solutions that can identify cancer at earlier stages, leading to better patient outcomes.

Regional Growth Outlook:

While the European market is expected to see a CAGR of 5.2%, other regions such as North America and Asia-Pacific are also contributing significantly to global market growth. However, Europe’s focus on healthcare infrastructure improvements, government initiatives, and advancements in medical research position the region as a key player in the cancer diagnostics landscape.

Rising Interest in Market Trends: Our Detailed Report Provides Essential Insights!

Future Prospects:

The future of cancer diagnostics lies in the integration of precision medicine, where diagnostics will play a crucial role in tailoring treatments to individual patients based on their genetic makeup and cancer characteristics. As Europe continues to invest in research and innovation, the market is expected to witness breakthroughs that will further accelerate growth.

As cancer continues to pose a global health challenge, the European cancer diagnostics market is poised for steady growth in the coming decade. With advancements in technology and a growing emphasis on early detection, Europe remains a critical player in shaping the future of cancer care.

Key Takeaways from the Global Cancer Diagnostics Market Study Report by FMI:

The net worth of the total cancer diagnostics business in the United States in the year 2022 was figured out to be 32.6% of the global market share. FMI further predicts substantial room for expansion in North America, given the increased incidence of cancer in the United States and Canada.
Europe, with a global market share of 30.1% in 2022, is also predicted to witness equal growth in most countries. Regional market players may take advantage of these chances by forging a solid presence and adjusting their product lines to suit local demands.
Based on FMI findings, Asia Pacific countries are poised to witness a greater growth trend during the forecast years. China, India, and Australia are the three prominent markets with anticipated CAGRs of 9.8%, 8.3%, and 13.4% between 2023 and 2033.

“Advancements in cancer diagnostics and rising prevalence of cancer are expected to aid growth of cancer diagnostics. A majority of leading players in cancer diagnostic market are adopting strategic partnerships to sustain the increasing competitive pressure,” Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Competitive Landscape for the Cancer Diagnostics Market Players:

Abbott Laboratories
Roche Holding AG
Thermo Fisher Scientific Inc.
Siemens AG
Bio Rad Laboratories Inc.
GE Healthcare
Illumina, Inc.
Bristol-Myers Squibb
Koninklijke Philips N.V.
Toshiba Medical Systems Corporation
Agilent Technologies Inc.

Some top players in this market. The leading market players that provide cutting-edge, easy-to-use diagnostic equipment have somewhat consolidated the market and are ideally positioned to profit from this expanding sector.

Worldwide, governments and medical institutions have also started extensive cancer screening programs, which has increased demand for cancer diagnostic services from private market players. So, existing and new market players now have exciting new prospects due to the rising demand for cancer diagnostics, particularly in the emerging economies. New diagnostic service companies may increase their clientele and get a competitive edge in the coming days by providing accurate and rapid findings.

Cancer Diagnostics Market by Category:

Test Type

Tumour Biomarkers Tests
- PSA Tests
- CTC Tests
- AFP Tests
- CA Tests
- HER2 Tests
- BRCA Tests
- ALK Tests
- CEA Tests
- EGFR Mutation Tests
- KRAS Mutation Tests
- Others
Imaging
- Ultrasound
- Mammography
- MRI Scan
- PET Scan
- CT Scan
- SPECT & Others
Biopsy
- Needle Biopsy
- Endoscopic Biopsy
- Bone Marrow Biopsy
- Others
Liquid Biopsy
Immunohistochemistry
In Situ Hybridization

Indication

Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Blood Cancer
Prostate Cancer
Ovarian Cancer
Stomach Cancer
Liver Cancer
Others

End-user

Hospital Associated Labs
Independent Diagnostic Laboratories
Diagnostic Imaging Centers
Cancer Research Institutes
Others

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Matched content

Editor’s pick